IssuEs in Palliative Care for People in Advanced and Terminal Stages of Young-onset and Late-Onset Dementia in GErmany

Palliative Care Clinical Trial

— EPYLOGE  

Official title:

IssuEs in Palliative Care for People in Advanced and Terminal Stages of Young-onset and Late-Onset Dementia in GErmany (EPYLOGE-Study)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03364179
• Other study ID #: PALLVFKS022EPYLOGE
• Status: Completed
• Start date: August 19, 2017
• Est. completion date: January 30, 2020

Study information

• Verified date: October 2020
• Source: Technische Universität München
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

From a scientific view, palliative care issues in dementia are neglected in Germany. Neither in Germany nor internationally research has been conducted on palliative care issues in young onset dementia (YOD), although significant differences compared to late onset dementia (LOD) are expected. Most international studies have focused on patients in long term care (LTC) facilities but have neglected patients that are cared for at home. We hypothesize that in advanced and terminal stages of YOD and LOD unmet care needs exist and that they differ between YOD and LOD. By prospectively assessing and surveying 200 patients with YOD and LOD in advanced stages who are cared for in LTC facilities and at home and investigating circumstances of death of 100 YOD- and LOD-patients, it is possible 1) to describe symptoms and management, health care utilization, palliative care provision, quality of life and death, elements of advance care planning, family caregivers' needs and satisfaction; 2) to compare YOD and LOD; 3) to develop expert-consensus recommendations derived from study results for the improvement and implementation of strategies and interventions for palliative care provision. 4) to communicate the recommendations nationally and internationally in order to improve and adapt guidelines, to implement the recommendations into daily practice and to give a basis and perspectives for future research projects; to communicate the results to patients and their families in order to counsel and support them in their decision making processes and their dialogue with professional caregivers and physicians.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 300
• Est. completion date: January 30, 2020
• Est. primary completion date: January 30, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patient with moderate or severe dementia (CDR = 2 or 3)

• Patient lives at home or in long term care

• Patient has got a family caregiver > 18 years

• Family caregiver has sufficient knowledge of German language

• Written informed consent of family caregiver

• Written informed consent of patient or legal representative, respectively

• Documents of legal representative/ Power of attorney

Exclusion criteria

• at least one inclusion criterion is not met

Related Conditions & MeSH terms

• Advanced Dementia Stages
• Dementia
• Palliative Care

Locations

Country	Name	City	State
Germany	Zentrum für kognitive Störungen, Psychiatrische Klinik und Poliklinik, Klinikum Rechts der Isar, TU München	München	Bayern

Sponsors (5)

Lead Sponsor	Collaborator
Technische Universität München	Centre Hospitalier Universitaire Vaudois, Deutsche Alzheimer Gesellschaft, German Federal Ministry of Education and Research, Ludwig-Maximilians - University of Munich

Country where clinical trial is conducted

Germany, 

References & Publications (1)

Diehl-Schmid J, Hartmann J, Roßmeier C, Riedl L, Förstl H, Egert-Schwender S, Kehl V, Schneider-Schelte H, Jox RJ. IssuEs in Palliative care for people in advanced and terminal stages of Young-onset and Late-Onset dementia in GErmany (EPYLOGE): the study protocol. BMC Psychiatry. 2018 Aug 31;18(1):271. doi: 10.1186/s12888-018-1846-0. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	patient´s quality of life in late stage dementia	Quality of ife in late-stage dementia scale (QUALID-Scale): 11 questions, Score 1 to 5 each, total sum score range 11 to 55, 11 means highest quality of life	Baseline
Primary	patient´s comfort of dying with dementia	Comfort assessment of dying with dementia (CAD-EOLD)-Scale: Subscale of End of Life in Dementia Scale (EOLD), 14 symptoms/ conditions during patient´s dying process to be rated by proxy, Score 1-3 each. Total sum score range 14 to 42. 42 means highest level of comfort during dying process.	Assessment B at the latest 4 months after patient's death
Secondary	symptoms and symptom management in late-stage dementia and during the dying process	adapted version of End of Life in Dementia -Symptom Management scale (SM-EOLD); patient´s examination; assessment of drug treatment and non-medical therapies by evaluation of medical files	Assessment A (study inclusion, patient is alive) and Assessment B (as soon as possible after patient´s death, at the latest 4 months after death)
Secondary	palliative care provision in late-stage dementia and during the dying process	semi-structured interviews with the caregiver to assess the status quo of (palliative) care issues (e.g. availability of general outpatient palliative care (AAPV), specialized outpatient palliative care (SAPV) or palliative care nurses; description of LTC setting; caregivers´experiences with palliative care)	Assessment A (inclusion, patient is alive) and Assessment B (as soon as possible after patient´s death, at the latest 4 months after death)
Secondary	health care utilization in late-stage dementia and during the dying process	semi-structured interviews with the caregivers	Assessment A (inclusion, patient is alive) and Assessment B (as soon as possible after patient´s death, at the latest 4 months after death)
Secondary	Caregivers' problems, challenges, barriers, needs, preferences in late-stage dementia and during the dying process	open questions to the family caregiver	Assessment A (inclusion, patient is alive) and Assessment B (as soon as possible after patient´s death, at the latest 4 months after death)
Secondary	family caregivers' burden and coping	various scales, e.g. the adapted version of Caregiver Strain Index (CSI)	Assessment A (inclusion, patient is alive) and Assessment B (as soon as possible after patient´s death, at the latest 4 months after death)
Secondary	family caregivers´satisfaction with care	various scales, e.g. the adapted version of End of life in dementia-Satisfaction with Care, (SWC-EOLD)	Assessment A (inclusion, patient is alive) and Assessment B (as soon as possible after patient´s death, at the latest 4 months after death)

External Links

•   EPYLOGE. Eine Studie zur Palliativversorgung bei Demenz in Deutschland